AzTrials
AzTrials

Diabetic Peripheral NeuropathyNCT07902297

Effects of Perturbation-Based Versus Conventional Balance Training on Reactive Stepping Ability in Patients With Diabetic Peripheral Neuropathy

A study testing Perturbation-Based Balance Training (PBBT) and Conventional Balance Training (CBT) in people with Diabetic Peripheral Neuropathy, run by Lahore University of Biological and Applied Sciences at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will compare perturbation-based balance training (PBBT) with conventional balance training in patients with diabetic peripheral neuropathy to assess reactive stepping ability, dynamic balance, and functional balance. Read more about this study

Who is it for?
Ages 45 to 65 years
Conditions the study is for
Diabetic Peripheral Neuropathy
What is being tested?
Perturbation-Based Balance Training (PBBT) and Conventional Balance Training (CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 sitePakistan
Study dates
12 Oct 2026to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 45-65 years of either gender.
  • Confirmed cases of diabetic peripheral neuropathy with a score ≥2.5 on physical examination using the Michigan Neuropathy Screening Instrument (MNSI).
  • Able to stand independently on a firm surface and walk independently without a walking aid.

Who cannot join

  • Patients with active diabetic foot ulcers, gangrene, severe peripheral vascular disease, or severe musculature disorder.
  • Any neurological condition other than peripheral neuropathy affecting balance or postural control.
  • Participants with any musculoskeletal condition, such as fracture, joint replacement, recent lower-limb or spinal surgery, or other balance-related musculoskeletal disorders that may affect balance, gait, or functional mobility will be excluded.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site, 1 recruiting
  • Gillani Physio & Joint Care

    Lahore, Punjab Province

    Dr. Syed Asadullah Arsalan Gillani, PHD, +923321483575, asadshahgilani@gmail.com

    Recruiting

Other trials in Pakistan

About this study

This study will compare perturbation-based balance training (PBBT) with conventional balance training in patients with diabetic peripheral neuropathy to assess reactive stepping ability, dynamic balance, and functional balance. Diabetic peripheral neuropathy is a prevalent complication of type 2 diabetes, affecting nearly 43% of diabetic patients in Pakistan. As a progressive condition, it leads to peripheral sensory loss, proprioceptive deficits, and delayed neuromuscular responses, all of which compromise balance and postural control and place this population at significantly elevated risk of falls.

In this study, a total of 40 adults with DPN will be randomly allocated into two groups: PBBT and CBT. Both groups will receive a total of 24 sessions with 3 supervised sessions per week for 8 weeks. The PBBT group will receive manually delivered, repeated, unexpected perturbations by a physical therapist. The CBT group will receive conventional balance training without perturbations. Outcome measures will include reactive stepping (Lean-and-Release Test), dynamic balance (Mini-BESTest), and functional balance (Berg Balance Scale). The assessment will be done at baseline, post-intervention (Week 8), and follow-up (Week 12). The study aims to determine which intervention provides superior improvement in reactive stepping and balance in patients with diabetic peripheral neuropathy.

Read the detailed description

Diabetic peripheral neuropathy (DPN) is one of the most prevalent complications of diabetes mellitus, contributing substantially to disability worldwide. As a progressive condition, DPN leads to peripheral sensory loss, proprioceptive deficits, and delayed neuromuscular responses, all of which compromise balance and postural control. Because reactive stepping depends on rapid, sensory-driven neuromuscular responses, this progressive sensory and motor decline delays the reactive stepping response required to arrest a fall, placing this population at significantly elevated risk of falls and fall-related injury. Current rehabilitation approaches have not adequately addressed this specific deficit. A review demonstrates that conventional balance training predominantly improves static and anticipatory balance, as it relies on predictable, self-initiated movements. However, these gains fail to transfer to the unpredictable, real-world balance challenges that precipitate most falls, since conventional protocols do not expose patients to the rapid, feedback-driven corrections that reactive stepping demands. This represents a critical limitation a need for an intervention that trains balance in controlled conditions. But it leaves the reflexive, protective response untrained while this mechanism is most directly implicated in fall prevention.

Perturbation-based balance training (PBBT) has emerged as a promising alternative, grounded in principles of neuroplasticity. It has shown effectiveness in retraining reactive postural responses across several neurological populations. Despite this, evidence evaluating its effectiveness specifically on reactive stepping in individuals with DPN remains limited.

Thus, the existing literature reveals a clear and clinically consequential gap as balance training interventions in DPN have been shown to improve anticipatory postural control and static balance. The reactive stepping, which is the last line of defense against falls during unexpected perturbations, remains largely untrained and underexplored. This study therefore aims to address this gap by evaluating the effectiveness of PBBT in enhancing reactive stepping ability in individuals with diabetic peripheral neuropathy. This study is designed as a two-arm, parallel-group randomized clinical trial to compare the effects of PBBT and CBT on reactive stepping ability, dynamic balance, and functional balance in individuals with DPN. A total of 40 participants will be recruited and randomly allocated into either the PBBT group or the CBT group in a 1:1 ratio using a computer-generated randomization sequence with allocation concealment through sequentially numbered, opaque, sealed envelopes (SNOSE). Participants in both groups will receive intervention for 8 weeks, with 3 supervised sessions per week, making a total of 24 sessions. Each 60-minute session will include 20 minutes of routine physical therapy (7 minutes of warm-up, 6 minutes of rest, and 7 minutes of cool-down) and a main intervention of 40 minutes. All participants will first receive an equal standardized baseline treatment for 2 weeks. Following this, from week 3 to week 8, the PBBT group will receive manually delivered repeated exposure to unexpected and externally imposed postural perturbations by a physical therapist in a standing position on stable and unstable surfaces, while the CBT group will receive balance training with eyes open and eyes closed in various conditions on stable and unstable surfaces, with no manual perturbations. Sessions will be delivered under safety procedures, including a support bar during perturbation tasks and pre-session blood glucose monitoring. Outcome measures will include reactive stepping ability assessed using the Lean-and-Release Test (primary outcome), dynamic balance assessed using the Mini-BESTest, and functional balance assessed using the Berg Balance Scale. Participants will be screened for DPN using the Michigan Neuropathy Screening Instrument (MNSI). Assessments will be conducted at baseline (Week 0), post-intervention (Week 8), and follow-up (Week 12) by a blinded outcome assessor. The findings of this study will provide comparative evidence regarding the effectiveness of PBBT and CBT in improving reactive stepping and balance in individuals with DPN. Because the proposed intervention requires only basic rehabilitation equipment, it may offer a practical, cost-effective, and scalable rehabilitation approach for reducing falls in resource-limited settings and may assist clinicians in selecting the most appropriate balance training approach for this patient population.

Being tested
Perturbation-Based Balance Training (PBBT), Conventional Balance Training (CBT)
Keywords
Diabetic Peripheral Neuropathy, Perturbation-based balance training, Conventional balance training, Reactive stepping, Reactive postural control, Balance training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Perturbation-Based Balance Training (PBBT)Behavioural

    Participants will receive routine physical therapy (7 minutes of warm-up, 6 minutes of rest, and 7 minutes of cool-down) along with perturbation-based balance training for 8 weeks, with 3 supervised sessions per week (24 sessions, 60 minutes each). After a 2-week shared familiarization phase (weeks 1-2), participants will receive manually delivered, repeated exposure to unexpected and externally imposed postural perturbations by a physical therapist in standing position on stable and unstable surfaces (weeks 3-8). Perturbations will progress from anterior and posterior to multi-directional and randomized, and from standing tasks to walking, uneven surfaces, and dual-task conditions, increasing from 10 to 15 perturbations per session. A support bar and pre-session blood glucose monitoring will be used for safety.

  • Conventional Balance Training (CBT)Behavioural

    Participants will receive routine physical therapy (7 minutes of warm-up, 6 minutes of rest, and 7 minutes of cool-down) along with conventional balance training for 8 weeks, with 3 supervised sessions per week (24 sessions, 60 minutes each). After a 2-week shared familiarization phase (weeks 1-2), participants will be trained for balance with eyes open and eyes closed in various conditions on stable and unstable surfaces, with no manual perturbations (weeks 3-8). Training will progress from foam-pad standing and weight shifting to functional gait tasks, obstacle negotiation, stair negotiation, and dual-task walking. A support bar and pre-session blood glucose monitoring will be used for safety.

Study groups in NCT07902297
Study groupRoleWhat they receive
PBBT GroupExperimentalArm Description: Group A will receive routine physical therapy along with perturbation-based balance training. After a 2-week shared familiarization phase (weeks 1-2), participants will receive manually delivered, repeated exposure to unexpected and externally imposed postural perturbations by a physical therapist in a standing position on stable and unstable surfaces (weeks 3-8). Sessions will be delivered 3 times per week for 8 weeks (24 sessions, 60 minutes each).
Receives: Behavioral: Perturbation-Based Balance Training (PBBT)
CBT GroupActive comparatorGroup B will receive routine physical therapy along with conventional balance training. After a 2-week shared familiarization phase (weeks 1-2), participants will be trained for balance with eyes open and eyes closed in various conditions on stable and unstable surfaces, with no manual perturbations (weeks 3-8). Sessions will be delivered 3 times per week for 8 weeks (24 sessions, 60 minutes each).
Receives: Behavioral: Conventional Balance Training (CBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reactive stepping ability (Lean-and-Release Test)

    The Lean-and-Release Test (LRT) will be used to assess reactive stepping ability. Participants stand barefoot in a standardized position and lean forward while the assessor supports them at the waist, bearing approximately 8-12% of their estimated body weight. The assessor then suddenly withdraws support, creating an unexpected forward perturbation that requires a rapid compensatory step. Each session consists of one unscored familiarization trial followed by 13 test trials (10 released trials and 3 false trials). The primary outcome is the proportion of successful single-step recovery trials out of the 10 released trials, with a higher proportion indicating better reactive stepping performance. The mean number of recovery steps across the 10 released trials will also be recorded, with a lower mean indicating greater reactive stepping efficiency.

    Measured: Baseline (Week 0), post-intervention (Week 8), and follow-up (Week 12)

Secondary outcomes (2)
  1. Dynamic balance (Mini-BESTest)

    The Mini-Balance Evaluation Systems Test (Mini-BESTest) assesses reactive postural control, anticipatory postural adjustments, sensory orientation, and dynamic gait stability. It has 14 items, each scored 0 to 2, with a maximum score of 28. Higher scores indicate better balance performance and lower fall risk, and a score below 20 commonly indicates increased fall risk.

    Measured: Baseline (Week 0), post-intervention (Week 8), and follow-up (Week 12)

  2. Functional balance (Berg Balance Scale)

    The Berg Balance Scale (BBS) assesses static and anticipatory balance during functional tasks such as standing, turning, reaching, and transferring. It has 14 items, each scored 0 to 4, with a maximum score of 56. Higher scores indicate better functional balance, and scores below 45 suggest increased fall risk.

    Measured: Baseline (Week 0), post-intervention (Week 8), and follow-up (Week 12)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2026
  2. Study start12 Oct 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07902297
Sponsor's protocol ID
UBAS/ERB/26/07/079
Status last verified
Oct 2026
First submitted
21 Oct 2026
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Perturbation-Based Balance Training (PBBT) and Conventional Balance Training (CBT) in people with Diabetic Peripheral Neuropathy, run by Lahore University of Biological and Applied Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr Shoaib Waqas (+92 302 4552109, shoaib.waqas@ubas.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reactive stepping ability (Lean-and-Release Test) (time frame: Baseline (Week 0), post-intervention (Week 8), and follow-up (Week 12)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in